Search Results - "Morabito, tunato"

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPI by Delgado, Julio, Doubek, Michael, Baumann, Tycho, Kotaskova, Jana, Molica, Stefano, Mozas, Pablo, Rivas‐Delgado, Alfredo, Morabito, Fortunato, Pospisilova, Sarka, Montserrat, Emili

“…Rai and Binet staging systems are important to predict the outcome of patients with chronic lymphocytic leukemia (CLL) but do not reflect the biologic…”
Get full text

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia by Rossi, Davide, Terzi-di-Bergamo, Lodovico, De Paoli, Lorenzo, Cerri, Michaela, Ghilardi, Guido, Chiarenza, Annalisa, Bulian, Pietro, Visco, Carlo, Mauro, Francesca R., Morabito, Fortunato, Cortelezzi, Agostino, Zaja, Francesco, Forconi, Francesco, Laurenti, Luca, Del Giudice, Ilaria, Gentile, Massimo, Vincelli, Iolanda, Motta, Marina, Coscia, Marta, Rigolin, Gian Matteo, Tedeschi, Alessandra, Neri, Antonino, Marasca, Roberto, Perbellini, Omar, Moreno, Carol, Del Poeta, Giovanni, Massaia, Massimo, Zinzani, Pier Luigi, Montillo, Marco, Cuneo, Antonio, Gattei, Valter, Foà, Robin, Gaidano, Gianluca

“…Fludarabine, cyclophosphamide, and rituximab (FCR) has represented a significant treatment advancement in chronic lymphocytic leukemia (CLL). In the new…”
Get full text

A Population-Based Analysis of the Cancer Incidence in Individuals under 50 in a Northern Italian Province: Focusing on Regional Disparities and Public Health Implications by Mangone, Lucia, Marinelli, Francesco, Bisceglia, Isabella, Roncaglia, Francesca, Morabito, Fortunato, Testa, Cinzia, Pinto, Carmine, Neri, Antonino

“…International studies have shown an increase in cancer incidence among young adults, raising public concern. This study aims examines trends in the cancer…”
Get full text

Iron chelation therapy by Bruzzese, Antonella, Martino, Enrica Antonia, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Bova, Carlo, Filippelli, Gianfranco, Capodanno, Isabella, Neri, Antonino, Morabito, Fortunato, Gentile, Massimo, Vigna, Ernesto

“…Iron overload is a pathological condition resulting from a congenital impairment of its regulation, increased intestinal iron absorption secondary to bone…”
Get full text

Teclistamab‐cqyv in multiple myeloma by Martino, Enrica Antonia, Bruzzese, Antonella, Labanca, Caterina, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Neri, Antonino, Morabito, Fortunato, Vigna, Ernesto, Gentile, Massimo

“…Multiple myeloma (MM) is an incurable neoplasm characterized by significant morbidity and mortality. Despite advances in treatment, MM patients eventually…”
Get full text

Belantamab mafodotin in multiple myeloma by Martino, Enrica Antonia, Bruzzese, Antonella, Iaccino, Enrico, Labanca, Caterina, Mendicino, Francesco, Mimmi, Selena, Lucia, Eugenio, Olivito, Virginia, Neri, Antonino, Morabito, Fortunato, Vigna, Ernesto, Gentile, Massimo

Get more information

Comparative Analysis of Bispecific Antibodies and CAR T-Cell Therapy in Follicular Lymphoma by Morabito, Fortunato, Martino, Enrica Antonia, Nizzoli, Maria Elena, Talami, Annalisa, Pozzi, Stefano, Martino, Massimo, Neri, Antonino, Gentile, Massimo

“…The treatment landscape for relapsed/refractory follicular lymphoma (RR-FL) is marked by a pivotal debate between chimeric antigen receptor T-cell (CAR-T)…”
Get full text

Therapy-Related Acute Promyelocytic Leukemia: Case Series and Current Insights by Bruzzese, Antonella, Martino, Enrica Antonia, Labanca, Caterina, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Morelli, Rosellina, Rossi, Teresa, Neri, Antonino, Morabito, Fortunato, Gentile, Massimo, Vigna, Ernesto

“…Therapy-related acute promyelocytic leukemia (t-APL) is rare and often linked to previous treatment with alkylating agents or topoisomerase II inhibitors. This…”
Get full text

Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications by Bruzzese, Antonella, Martino, Enrica Antonia, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Capodanno, Isabella, Neri, Antonino, Morabito, Fortunato, Vigna, Ernesto, Gentile, Massimo

“…Myelodysplastic syndromes (MDS) encompass a heterogeneous set of acquired bone marrow neoplastic disorders characterized by ineffective hematopoiesis within…”
Get full text

Venetoclax in acute myeloid leukemia by Bruzzese, Antonella, Martino, Enrica Antonia, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Neri, Antonino, Morabito, Fortunato, Vigna, Ernesto, Gentile, Massimo

Get more information

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers by Van Roosbroeck, Katrien, Fanini, Francesca, Setoyama, Tetsuro, Ivan, Cristina, Rodriguez-Aguayo, Cristian, Fuentes-Mattei, Enrique, Xiao, Lianchun, Vannini, Ivan, Redis, Roxana S, D'Abundo, Lucilla, Zhang, Xinna, Nicoloso, Milena S, Rossi, Simona, Gonzalez-Villasana, Vianey, Rupaimoole, Rajesha, Ferracin, Manuela, Morabito, Fortunato, Neri, Antonino, Ruvolo, Peter P, Ruvolo, Vivian R, Pecot, Chad V, Amadori, Dino, Abruzzo, Lynne, Calin, Steliana, Wang, Xuemei, You, M James, Ferrajoli, Alessandra, Orlowski, Robert, Plunkett, William, Lichtenberg, Tara M, Davuluri, Ramana V, Berindan-Neagoe, Ioana, Negrini, Massimo, Wistuba, Ignacio I, Kantarjian, Hagop M, Sood, Anil K, Lopez-Berestein, Gabriel, Keating, Michael J, Fabbri, Muller, Calin, George A

“…The oncogenic miR-155 is upregulated in many human cancers, and its expression is increased in more aggressive and therapy-resistant tumors, but the molecular…”
Get full text

Isatuximab in multiple myeloma by Martino, Enrica Antonia, Bruzzese, Antonella, Iaccino, Enrico, Mendicino, Francesco, Mimmi, Selena, Lucia, Eugenio, Olivito, Virginia, Neri, Antonino, Morabito, Fortunato, Vigna, Ernesto, Gentile, Massimo

Get more information

Elotuzumab in multiple myeloma by Bruzzese, Antonella, Martino, Enrica Antonia, Vigna, Ernesto, Iaccino, Enrico, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Filippelli, Gianfranco, Neri, Antonino, Morabito, Fortunato, Gentile, Massimo

Get more information

Momelotinib in myelofibrosis by Bruzzese, Antonella, Martino, Enrica Antonia, Labanca, Caterina, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Zimbo, Annamaria, Fragliasso, Valentina, Neri, Antonino, Morabito, Fortunato, Vigna, Ernesto, Gentile, Massimo

“…Myelofibrosis (MF) is a hematologic disease characterized by bone marrow fibrosis, cytopenias, splenomegaly, and constitutional symptoms. Recent years have…”
Get more information

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial by PALUMBO, Antonio, BRINGHEN, Sara, BENEVOLO, Giulia, CALLEA, Vincenzo, BALDINI, Luca, MORABITO, Fortunato, GRASSO, Mariella, LEONARDI, Giovanna, RIZZO, Manuela, FALCONE, Antonietta Pia, GOTTARDI, Daniela, MONTEFUSCO, Vittorio, ROSSI, Davide, MUSTO, Pellegrino, PETRUCCI, Maria Teresa, CICCONE, Giovannino, BOCCADORO, Mario, CAVALLI, Maide, LAROCCA, Alessandra, RIA, Roberto, OFFIDANI, Massimo, PATRIARCA, Francesca, NOZZOLI, Chiara, GUGLIELMELLI, Tommasina

“…The combination of bortezomib-melphalan-prednisone (VMP) is a new standard of care for newly diagnosed multiple myeloma. This phase III study examined the…”
Get full text

DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome by Todoerti, Katia, Ronchetti, Domenica, Favasuli, Vanessa, Maura, Francesco, Morabito, Fortunato, Bolli, Niccolò, Taiana, Elisa, Neri, Antonino

“…DIS3 gene mutations occur in roughly 10% of patients with multiple myeloma (MM); furthermore, DIS3 expression can be affected by monosomy 13 and del(13q),…”
Get full text

Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study by Bomben, Riccardo, Rossi, Francesca Maria, Vit, Filippo, Bittolo, Tamara, Zucchetto, Antonella, Papotti, Robel, Tissino, Erika, Pozzo, Federico, Degan, Massimo, Polesel, Jerry, Bulian, Pietro, Marasca, Roberto, Reda, Gianluigi, Laurenti, Luca, Olivieri, Jacopo, Chiarenza, Annalisa, Laureana, Roberta, Postorino, Massimiliano, Del Principe, Maria Ilaria, Cuneo, Antonio, Gentile, Massimo, Morabito, Fortunato, Fronza, Gilberto, Tafuri, Agostino, Zaja, Francesco, Foà, Robin, Di Raimondo, Francesco, Del Poeta, Giovanni, Gattei, Valter

Get full text

Ivosidenib in acute myeloid leukemia by Bruzzese, Antonella, Labanca, Caterina, Martino, Enrica Antonia, Mendicino, Francesco, Lucia, Eugenio, Olivito, Virginia, Neri, Antonino, Imovilli, Annalisa, Morabito, Fortunato, Vigna, Ernesto, Gentile, Massimo

“…Traditional treatment strategies for acute myeloid leukemia (AML) have primarily relied on standard chemotherapy regimens for four decades. Indeed, the…”
Get more information

TP53 Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia by Bomben, Riccardo, Rossi, Francesca Maria, Vit, Filippo, Bittolo, Tamara, D'Agaro, Tiziana, Zucchetto, Antonella, Tissino, Erika, Pozzo, Federico, Vendramini, Elena, Degan, Massimo, Zaina, Eva, Cattarossi, Ilaria, Varaschin, Paola, Nanni, Paola, Berton, Michele, Braida, Alessandra, Polesel, Jerry, Cohen, Jared A, Santinelli, Enrico, Biagi, Annalisa, Gentile, Massimo, Morabito, Fortunato, Fronza, Gilberto, Pozzato, Gabriele, D'Arena, Giovanni, Olivieri, Jacopo, Bulian, Pietro, Pepper, Chris, Hockaday, Anna, Schuh, Anna, Hillmen, Peter, Rossi, Davide, Chiarenza, Annalisa, Zaja, Francesco, Di Raimondo, Francesco, Del Poeta, Giovanni, Gattei, Valter

“…In chronic lymphocytic leukemia (CLL), mutations are associated with reduced survival and resistance to standard chemoimmunotherapy (CIT). Nevertheless, the…”
Get full text

Autologous stem cell transplantation in multiple myeloma is not dead but alive and well by Martino, Massimo, Morabito, Fortunato

“…In multiple myeloma (MM), the use of high-dose chemotherapy with autologous stem cell transplantation (ASCT) led to incremental advances in patient management…”
Get more information